|
MICALL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.438200E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.197600E-02 |
| Normal-vs-Stage2 |
3.298300E-02 |
| Normal-vs-Stage3 |
1.376260E-02 |
| Normal-vs-Stage4 |
1.00110000289533E-08 |
| Stage1-vs-Stage2 |
9.459200E-01 |
| Stage1-vs-Stage3 |
6.793000E-01 |
| Stage1-vs-Stage4 |
3.34290000003623E-06 |
| Stage2-vs-Stage3 |
7.952000E-01 |
| Stage2-vs-Stage4 |
2.436800E-03 |
| Stage3-vs-Stage4 |
3.998200E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.004500E-03 |
| Normal-vs-AfricanAmerican |
5.030100E-02 |
| Normal-vs-Asian |
1.239620E-03 |
| Caucasian-vs-AfricanAmerican |
8.701200E-01 |
| Caucasian-vs-Asian |
3.554000E-01 |
| AfricanAmerican-vs-Asian |
7.480000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.844600E-04 |
| Normal-vs-Female |
1.920840E-03 |
| Male-vs-Female |
2.934400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.998000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.002900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.726000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.395770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.136000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.557600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.705200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.229400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.114600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.941600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.779400E-01 |
| Classical-VS-Follicular |
3.981000E-01 |
| Classical-VS-Other |
2.285400E-01 |
| Classical-VS-Normal |
1.356870E-03 |
| Tall-VS-Follicular |
6.093200E-01 |
| Tall-VS-Other |
5.406600E-01 |
| Tall-VS-Normal |
1.136040E-01 |
| Follicular-VS-Other |
2.250400E-01 |
| Follicular-VS-Normal |
5.111700E-02 |
| Other-VS-Normal |
9.516800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.072200E-02 |
| Normal-vs-N1 |
4.545200000039E-06 |
| N0-vs-N1 |
3.975100E-03 |
|
|
